These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Dexamethasone suppression test versus selective ovarian and adrenal vein catheterization in identifying virilizing tumors in postmenopausal hyperandrogenism - a systematic review and meta-analysis. Tng EL, Tan JM. Gynecol Endocrinol; 2021 Jul; 37(7):600-608. PubMed ID: 33660585 [Abstract] [Full Text] [Related]
34. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. Rosenfield RL, Barnes RB, Ehrmann DA, Toledano AY. J Clin Endocrinol Metab; 2003 Dec; 88(12):6115; author reply 6115-6. PubMed ID: 14671222 [No Abstract] [Full Text] [Related]
35. Relation of adrenal androgen to insulin levels. Nestler JE. Ann Intern Med; 1993 May 15; 118(10):826. PubMed ID: 8470862 [No Abstract] [Full Text] [Related]
36. [Effect of low doses of dexamethasone in the treatment of hyperandrogenism of adrenal origin]. Legros JJ, Remacle B, Franchimont P, Palem-Vliers M, Genard P, Van Cauwenberge H. Rev Med Liege; 1978 Oct 01; 33(19):665-71. PubMed ID: 705144 [No Abstract] [Full Text] [Related]
37. Characterization and measurement of dehydroepiandrosterone sulfate in rat brain. Corpéchot C, Robel P, Axelson M, Sjövall J, Baulieu EE. Proc Natl Acad Sci U S A; 1981 Aug 01; 78(8):4704-7. PubMed ID: 6458035 [Abstract] [Full Text] [Related]